Adjuvant Capital Impact Investors
Adjuvant Capital is a life sciences investment firm focused on global health.
Technology:
COVID-19 Investors
Headquarters:
New York, New York, United States
Funding Status:
N/A
Investment Stage:
Early Stage Venture, Late Stage Venture, Venture
Founded Date:
2012-01-01
Number Of Exists:
2
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Total Funding:
N/A
Industry:
N/A
Investor Type:
Venture Capital